Pegylated interferon α and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients

General Hospital Psychiatry

Volumn 30, Issue 6, 2008, Pages 501-508

  Pawelczyk, Tomasz ^a   Pawelczyk, Agnieszka ^b   Strzelecki, Dominik ^a   Rabe Jablonska, Jolanta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Outpatient Psychological Clinic   (Poland)

Author keywords

Chronic hepatitis C; Interferon ; Memory and cognitive disorders; Organic mood disorders; Ribavirin

Indexed keywords

PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; AGED; ANOREXIA; ARTICLE; ATTENTION DISTURBANCE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEPRESSION; FATIGUE; FEMALE; HEPATITIS C; HUMAN; IRRITABILITY; MALE; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; SIDE EFFECT; TREATMENT DURATION; WORKING MEMORY DISTURBANCE;

ADULT; AGED; ANTIVIRAL AGENTS; ATTENTION; DISCRIMINATION LEARNING; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYETHYLENE GLYCOLS; PROBLEM SOLVING; RIBAVIRIN; YOUNG ADULT;

EID: 54349087525     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2008.03.001     Document Type: Article

References (39)

1. Hilsabeck R.C., Hassanein T.I., Carlson M.D., Ziegler E.A., and Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc 9 (2003) 847-854
2. Weissenborn K., Krause J., Bokemeyer M., et al. Hepatitis C virus infection affects the brain - evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 41 (2004) 845-851
3. Manns M.P., McHutchison J.G., Gordon S.C., et al. Peg interferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358 (2001) 958
4. Lauer G.M., and Walker B.D. Hepatitis C virus infection. N Engl J Med 345 (2001) 41
5. Dwight M.M., Kowdley K.V., Russo J.E., et al. Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychosom Res 49 (2000) 311
6. Neumann A.U., Lam N.P., Dahari H., et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282 (1998) 103-107
7. Schaefer M., Engelbrecht M.A., Gut O., et al. Interferon alpha (IFNalpha) and psychiatric syndromes: a review. Prog Neuropsychopharmacol Biol Psychiatry 26 (2002) 731-746
8. Kraus M.R., Schafer A., Csef H., and Scheurlen M. Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C. World J Gastroenterol 11 (2005) 1769-1774
9. Capuron L., Gumnick J.F., Musselman D.L., et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26 (2002) 643-652
10. Caraceni A., Gangeri L., Martini C., et al. Neurotoxicity of interferon-alpha in melanoma therapy: results from a randomized controlled trial. Cancer 83 (1998) 482-489
11. Kamei S., Sakai T., Matsuura M., et al. Alterations of quantitative EEG and Mini-Mental State Examination in interferon-alpha-treated hepatitis C. Eur Neurol 48 (2002) 102-107
12. Smith A., Tyrrell D., Coyle K., and Higgins P. Effects of interferon alpha on performance in man: a preliminary report. Psychopharmacology (Berl) 96 (1988) 414
13. Valentine A.D., Meyers C.A., Kling M.A., Richelson E., and Hauser P. Mood and cognitive side effects of interferon-alpha therapy. Semin Oncol 25 (1998) 39
14. Amodio P., De Toni E.N., Cavalletto L., et al. Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C. J Affect Disord 84 (2005) 93-98
15. Fontana R.J., Bieliauskas L.A., Lindsay K.L., et al. Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C. Hepatology 45 (2007) 1154-1163
16. Hilsabeck R.C., Hassanein T.I., Ziegler E.A., Carlson M.D., and Perry W. Effect of interferon-alpha on cognitive functioning in patients with chronic hepatitis C. J Int Neuropsychol Soc 11 (2005) 16-22
17. Lieb K., Engelbrecht M.A., Gut O., et al. Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNalpha): results from a prospective study. Eur Psychiatry 21 (2006) 204-210
18. Sheehan D.V., Lecrubier Y., Sheehan K.H., et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 20 (1998) 22-33 quiz 34-57
19. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 561-571
20. Reitan R.M. Validity of Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 8 (1958) 271-276
21. Stroop J.R. Studies of interference in serial verbal reactions. J Exp Psychol 18 (1935) 643-661
22. Lezak M.D., Howieson D.B., and Loring D.W. Neuropsychological assessment (2004), Oxford University Press, New York
23. Houx P.J., Jolles J., and Vreeling F.W. Stroop interference: aging effects assessed with the Stroop Color-Word Test. Exp Aging Res 19 (1993) 209-224
24. Klein M., Ponds R.W., Houx P.J., and Jolles J. Effect of test duration on age-related differences in Stroop interference. J Clin Exp Neuropsychol 19 (1997) 77-82
25. Posner M.I., and DiGirolamo G.J. Executive attention: conflict, target detection and cognitive control. In: Parasuraman R. (Ed). The attentive brain (1998), MIT Press
26. Bush G., Luu P., and Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 4 (2000) 215-222
27. Carter C.S., Macdonald A.M., Botvinick M., et al. Parsing executive processes: strategic vs. evaluative functions of the anterior cingulate cortex. Proc Natl Acad Sci U S A 97 (2000) 1944-1948
28. Dusheiko G. Side effects of alpha interferon in chronic hepatitis C. Hepatology 26 (1997) 112S
29. McHutchison J.G., Gordon S.C., Schiff E.R., et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339 (1998) 1485
30. Reichenberg A., Gorman J.M., and Dieterich D.T. Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study. Aids 19 Suppl 3 (2005) S174-S178
31. Fan J., Kolster R., Ghajar J., et al. Response anticipation and response conflict: an event-related potential and functional magnetic resonance imaging study. J Neurosci 27 (2007) 2272-2282
32. Kondo H., Osaka N., and Osaka M. Cooperation of the anterior cingulate cortex and dorsolateral prefrontal cortex for attention shifting. NeuroImage 23 (2004) 670-679
33. Meyers C.A., Obbens E.A., Scheibel R.S., and Moser R.P. Neurotoxicity of intraventricularly administered alpha-interferon for leptomeningeal disease. Cancer 68 (1991) 88-92
34. Meyers C.A., Scheibel R.S., and Forman A.D. Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 41 (1991) 672
35. Pavol M.A., Meyers C.A., Rexer J.L., et al. Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia. Neurology 45 (1995) 947
36. Juengling F.D., Ebert D., Gut O., et al. Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology (Berl) 152 (2000) 383
37. Capuron L., Pagnoni G., Demetrashvili M., et al. Anterior cingulate activation and error processing during interferon-alpha treatment. Biol Psychiatry 58 (2005) 190-196
38. Capuron L., and Dantzer R. Cytokines and depression: the need for a new paradigm. Brain Behav Immun 17 Suppl 1 (2003) S119-S124
39. Capuron L., and Miller A.H. Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 56 (2004) 819-824